Using its Promarker technology platform, the company has identified the biomarkers in the blood (biological fingerprints) of kidney disease in diabetics, specifically Type 2 diabetes. Using this information the company has developed PromarkerD, a diagnostic test that accurately predicts whether people with diabetes will develop chronic kidney disease.

We have assigned 1AL a target price of $1.32 per share. 1AL designs, manufactures and distributes outdoor furniture around the world. The company owns and operates its manufacturing facility in Guangdong, China, where the company’s key products are produced.

Todd River Resources (ASX: TRT, Todd River or“the Company”) is a Northern Territory explorer, with a diverse portfolio of greenfields to advanced exploration and near development assets over a wide range of prospective geological settings, including those with known world-class deposits. Having recently listed on the ASX via an oversubscribed spin out from TNG limited, Todd River is well cashed up, with ~$5.5 million in the bank.

The Company reported a net loss after tax of $45.1m on the back of increasing costs. Revenue continued to improve, up 33.4% on the pcp, driven by increased rental income. Rental income continues to improve as the number of properties leased increases. The Fund reported a loss before tax of $27.0m, its first full year loss before tax since listing in 2012.

With combined neodymium and praseodymium (commonly referred to jointly as “didymium”) grades of ~0.4%, or 33% of the total rare earths oxide ("TREO") grade of 1.18%, Yangibana has a relatively high content of these two rare earths oxides (“REO”) that are considered to provide the strongest growth potential in the rare earths space over the short to medium term.